Researchers develop new AI tool to predict heart attack risk
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Heart, News & EventsResearchers from the Harry Perkins Institute of Medical Research, working with medtech industry partners Artrya Limited, have developed a new, fully-automated AI algorithm that is more effective than current methods…
Perkins researchers put paid to plaque in arteries
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Cell Signalling, Donation Handles, Funding, Heart, Imaging and Therapy, Media Releases, News & Events, Research, Sarcoma, Targeted Drug Delivery, TreatmentsThe Harry Perkins Institute of Medical Research is celebrating a major milestone in the progression of a world-first drug candidate that has the potential to change the lives of thousands…
New heart health trial targets families with history of early heart attacks
By Richard Schoonraad | Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Cell Signalling, Community, Donation Handles, Heart, News & Events, Research, SarcomaA pioneering new study led by cardiologist Associate Professor Abdul Ihdayhid from the Harry Perkins Institute of Medical Research and Curtin University is offering new hope to families affected by…
Genetic tests to identify people at higher risk of heart failure
By Alicia Bienkowski | APEXHeart Lab, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Centre for Diabetes Research, Heart, Lab, Media Releases, News & Events, ResearchA groundbreaking study by researchers at Perth’s Harry Perkins Institute of Medical Research has produced a genetic test for heart failure, which will enable early intervention and more personalised treatment…
AI stethoscope to help detect early signs of heart disease
By Richard Schoonraad | APEXHeart Lab, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, News & Events, TreatmentsNew AI stethoscope could revolutionise medicine and help detect the early signs of heart valve disease A digital stethoscope that will easily be able to detect early signs of heart…
3D Printed heart valves to be commercialised
By Richard Schoonraad | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, T3mPLATE Laboratory, Vascular EngineeringCutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…
Further mysteries of cardiovascular disease-causing plaque revealed
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Media Releases, News & Events, ResearchNew discoveries on where plaque can form and what can trigger a heart attack. Researchers from the Harry Perkins Institute of Medical Research have published new findings that turn the…
MinRes’ $2 million heart research investment welcomed
By Alicia Bienkowski | Cardiovascular Disease, Heart, Media Releases, News & Events, ResearchHeart attack statistics 50 Australians die every day from a heart attack Nearly 20,000 Australians die each year from heart attack 160 heart attacks occur every day The cost per…